© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Greater China

  • The People’s Bank of China will issue bills worth Rmb20bn ($2.87bn) in Hong Kong next week, in what analysts see as a signal of closer oversight of offshore renminbi (CNH) liquidity.
  • A flexible approach allowed Shangri-La Hotel to tap into the Singapore dollar bond market on Thursday for S$825m, a rare outing that helped it stave off pressing loan liabilities.
  • Changchun Urban Development & Investment Holdings (Group) Co leveraged on its positioning as a key infrastructure investment and construction company for the local Chinese government to woo investors to its $400m bond return on Thursday.
  • Two Chinese companies, Guodong Network Communications and Bestway Global Holding, have ventured out for their maiden loans, seeking €150m ($170m) and $150m respectively.
  • Is banking due its own #MeToo moment? So far, there have been few whistle blowers in this testosterone filled industry, perhaps suggesting either that banks are much less sexist than some might fear, or that there are still a lot of stories yet to surface.
  • BNP Paribas has seen two senior changes in its Asia business recently, according to multiple sources close to the situation.
  • China National Bluestar (Group) Co paid a handsome new issue premium for a $300m senior perpetual bond amid weak sentiment for the structure, as its deal caused a widening in the broader Chinese senior perp market.
  • China Evergrande Group’s $1.8bn return to the bond market this week split opinion. The ultra-high yield deal, which sent the company’s secondary bonds spiralling, was largely sold to Evergrande’s chairman — a move that attracted a mix of outrage and admiration. Morgan Davis reports.
  • A stunning rally in Innovent Biologics caught the market’s attention this week, after the shares surged as much as 46% following their debut in Hong Kong on Wednesday. But whether it marks a turning point for the city’s biotechnology listings — which have performed dismally in the secondary market so far — is less clear, writes John Loh.
  • S&P Global Ratings is expecting to get regulatory approval to set up in China as early as November as the race to disrupt the onshore ratings market heats up, writes Paolo Danese.
  • Agricultural Bank of China's Hong Kong branch became one of only two issuers to print floating rate notes (FRNs) in October, raising $800m on Wednesday.
  • Bank of America Merrill Lynch has promoted Jessica Li to head of healthcare investment banking for Asia.